Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
-
Delisted patents from the Rx, OTC, and Disc drug lists are displayed in individual tables below.
The following search results are a list of patents that have been DELISTED from the latest Edition (delistings since January 25, 2012) of the Orange Book. Search results display delisted patents from drug products on the RX list.
| Appl No | Prod No | Active Ingredient | Proprietary Name | Delisted Patent | |
|---|---|---|---|---|---|
| N202258 | 001 | BOCEPREVIR | VICTRELIS | 7012066 | |
|
|
|||||
| N022012 | 003 | CARVEDILOL PHOSPHATE | COREG CR | 5902821 | |
|
|
|||||
| N022012 | 003 | CARVEDILOL PHOSPHATE | COREG CR | 5902821 | |
|
|
|||||
| N022012 | 003 | CARVEDILOL PHOSPHATE | COREG CR | 5902821*PED | |
|
|
|||||
| N022012 | 004 | CARVEDILOL PHOSPHATE | COREG CR | 5902821 | |
|
|
|||||
| N022012 | 004 | CARVEDILOL PHOSPHATE | COREG CR | 5902821 | |
|
|
|||||
| N022012 | 004 | CARVEDILOL PHOSPHATE | COREG CR | 5902821*PED | |
|
|
|||||
| N022012 | 001 | CARVEDILOL PHOSPHATE | COREG CR | 5902821 | |
|
|
|||||
| N022012 | 001 | CARVEDILOL PHOSPHATE | COREG CR | 5902821 | |
|
|
|||||
| N022012 | 001 | CARVEDILOL PHOSPHATE | COREG CR | 5902821*PED | |
|
|
|||||
| N022012 | 002 | CARVEDILOL PHOSPHATE | COREG CR | 5902821 | |
|
|
|||||
| N022012 | 002 | CARVEDILOL PHOSPHATE | COREG CR | 5902821 | |
|
|
|||||
| N022012 | 002 | CARVEDILOL PHOSPHATE | COREG CR | 5902821*PED | |
|
|
|||||
| N020839 | 001 | CLOPIDOGREL BISULFATE | PLAVIX | 5576328 | |
|
|
|||||
| N020839 | 001 | CLOPIDOGREL BISULFATE | PLAVIX | 5576328*PED | |
|
|
|||||
| N020690 | 002 | DONEPEZIL HYDROCHLORIDE | ARICEPT | 6372760 | |
|
|
|||||
| N020690 | 001 | DONEPEZIL HYDROCHLORIDE | ARICEPT | 6372760 | |
|
|
|||||
| N021565 | 001 | EPINASTINE HYDROCHLORIDE | ELESTAT | 7429602 | |
|
|
|||||
| N021172 | 004 | INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT | NOVOLOG MIX 70/30 FLEXPEN | 6235004 | |
|
|
|||||
| N020986 | 003 | INSULIN ASPART RECOMBINANT | NOVOLOG FLEXPEN | 6235004 | |
|
|
|||||
| N020986 | 003 | INSULIN ASPART RECOMBINANT | NOVOLOG FLEXPEN | 6235004*PED | |
|
|
|||||
| N021536 | 002 | INSULIN DETEMIR RECOMBINANT | LEVEMIR FLEXPEN | 6235004 | |
|
|
|||||
| N022341 | 001 | LIRAGLUTIDE RECOMBINANT | VICTOZA | 6235004 | |
|
|
|||||
| N013217 | 003 | METAXALONE | SKELAXIN | 6407128 | |
|
|
|||||
| N013217 | 003 | METAXALONE | SKELAXIN | 6683102 | |
|
|
|||||
| N020868 | 001 | METRONIDAZOLE | FLAGYL ER | 6103262 | |
|
|
|||||
| N020592 | 005 | OLANZAPINE | ZYPREXA | 5605897 | |
|
|
|||||
| N020592 | 005 | OLANZAPINE | ZYPREXA | 5605897*PED | |
|
|
|||||
| N020592 | 005 | OLANZAPINE | ZYPREXA | 5736541 | |
|
|
|||||
| N020592 | 005 | OLANZAPINE | ZYPREXA | 5736541*PED | |
|
|
|||||
| N020592 | 005 | OLANZAPINE | ZYPREXA | 5919485 | |
|
|
|||||
| N020592 | 005 | OLANZAPINE | ZYPREXA | 5919485*PED | |
|
|
|||||
| N020592 | 005 | OLANZAPINE | ZYPREXA | 6251895 | |
|
|
|||||
| N020592 | 005 | OLANZAPINE | ZYPREXA | 6251895*PED | |
|
|
|||||
| N020592 | 006 | OLANZAPINE | ZYPREXA | 5605897 | |
|
|
|||||
| N020592 | 006 | OLANZAPINE | ZYPREXA | 5605897*PED | |
|
|
|||||
| N020592 | 006 | OLANZAPINE | ZYPREXA | 5736541 | |
|
|
|||||
| N020592 | 006 | OLANZAPINE | ZYPREXA | 5736541*PED | |
|
|
|||||
| N020592 | 006 | OLANZAPINE | ZYPREXA | 5919485 | |
|
|
|||||
| N020592 | 006 | OLANZAPINE | ZYPREXA | 5919485*PED | |
|
|
|||||
| N020592 | 006 | OLANZAPINE | ZYPREXA | 6251895 | |
|
|
|||||
| N020592 | 006 | OLANZAPINE | ZYPREXA | 6251895*PED | |
|
|
|||||
| N020592 | 002 | OLANZAPINE | ZYPREXA | 5605897 | |
|
|
|||||
| N020592 | 002 | OLANZAPINE | ZYPREXA | 5605897*PED | |
|
|
|||||
| N020592 | 002 | OLANZAPINE | ZYPREXA | 5736541 | |
|
|
|||||
| N020592 | 002 | OLANZAPINE | ZYPREXA | 5736541*PED | |
|
|
|||||
| N020592 | 002 | OLANZAPINE | ZYPREXA | 5919485 | |
|
|
|||||
| N020592 | 002 | OLANZAPINE | ZYPREXA | 5919485*PED | |
|
|
|||||
| N020592 | 002 | OLANZAPINE | ZYPREXA | 6251895 | |
|
|
|||||
| N020592 | 002 | OLANZAPINE | ZYPREXA | 6251895*PED | |
|
|
|||||
| N020592 | 001 | OLANZAPINE | ZYPREXA | 5605897 | |
|
|
|||||
| N020592 | 001 | OLANZAPINE | ZYPREXA | 5605897*PED | |
|
|
|||||
| N020592 | 001 | OLANZAPINE | ZYPREXA | 5736541 | |
|
|
|||||
| N020592 | 001 | OLANZAPINE | ZYPREXA | 5736541*PED | |
|
|
|||||
| N020592 | 001 | OLANZAPINE | ZYPREXA | 5919485 | |
|
|
|||||
| N020592 | 001 | OLANZAPINE | ZYPREXA | 5919485*PED | |
|
|
|||||
| N020592 | 001 | OLANZAPINE | ZYPREXA | 6251895 | |
|
|
|||||
| N020592 | 001 | OLANZAPINE | ZYPREXA | 6251895*PED | |
|
|
|||||
| N020592 | 003 | OLANZAPINE | ZYPREXA | 5605897 | |
|
|
|||||
| N020592 | 003 | OLANZAPINE | ZYPREXA | 5605897*PED | |
|
|
|||||
| N020592 | 003 | OLANZAPINE | ZYPREXA | 5736541 | |
|
|
|||||
| N020592 | 003 | OLANZAPINE | ZYPREXA | 5736541*PED | |
|
|
|||||
| N020592 | 003 | OLANZAPINE | ZYPREXA | 5919485 | |
|
|
|||||
| N020592 | 003 | OLANZAPINE | ZYPREXA | 5919485*PED | |
|
|
|||||
| N020592 | 003 | OLANZAPINE | ZYPREXA | 6251895 | |
|
|
|||||
| N020592 | 003 | OLANZAPINE | ZYPREXA | 6251895*PED | |
|
|
|||||
| N020592 | 004 | OLANZAPINE | ZYPREXA | 5605897 | |
|
|
|||||
| N020592 | 004 | OLANZAPINE | ZYPREXA | 5605897*PED | |
|
|
|||||
| N020592 | 004 | OLANZAPINE | ZYPREXA | 5736541 | |
|
|
|||||
| N020592 | 004 | OLANZAPINE | ZYPREXA | 5736541*PED | |
|
|
|||||
| N020592 | 004 | OLANZAPINE | ZYPREXA | 5919485 | |
|
|
|||||
| N020592 | 004 | OLANZAPINE | ZYPREXA | 5919485*PED | |
|
|
|||||
| N020592 | 004 | OLANZAPINE | ZYPREXA | 6251895 | |
|
|
|||||
| N020592 | 004 | OLANZAPINE | ZYPREXA | 6251895*PED | |
|
|
|||||
| N021299 | 001 | PAROXETINE MESYLATE | PEXEVA | 6703408 | |
|
|
|||||
| N021299 | 001 | PAROXETINE MESYLATE | PEXEVA | 7598271 | |
|
|
|||||
| N021299 | 002 | PAROXETINE MESYLATE | PEXEVA | 6703408 | |
|
|
|||||
| N021299 | 002 | PAROXETINE MESYLATE | PEXEVA | 7598271 | |
|
|
|||||
| N021299 | 003 | PAROXETINE MESYLATE | PEXEVA | 6703408 | |
|
|
|||||
| N021299 | 003 | PAROXETINE MESYLATE | PEXEVA | 7598271 | |
|
|
|||||
| N021299 | 004 | PAROXETINE MESYLATE | PEXEVA | 6703408 | |
|
|
|||||
| N021299 | 004 | PAROXETINE MESYLATE | PEXEVA | 7598271 | |
|
|
|||||
| N022307 | 001 | PRASUGREL HYDROCHLORIDE | EFFIENT | 6693115 | |
|
|
|||||
| N022307 | 002 | PRASUGREL HYDROCHLORIDE | EFFIENT | 6693115 | |
|
|
|||||
| N020588 | 001 | RISPERIDONE | RISPERDAL | 5616587 | |
|
|
|||||
| N020588 | 001 | RISPERIDONE | RISPERDAL | 5616587*PED | |
|
|
|||||
| N021346 | 004 | RISPERIDONE | RISPERDAL CONSTA | 6110503 | |
|
|
|||||
| N021346 | 004 | RISPERIDONE | RISPERDAL CONSTA | 6110503*PED | |
|
|
|||||
| N021346 | 004 | RISPERIDONE | RISPERDAL CONSTA | 6667061 | |
|
|
|||||
| N021346 | 004 | RISPERIDONE | RISPERDAL CONSTA | 6667061*PED | |
|
|
|||||
| N021148 | 007 | SOMATROPIN RECOMBINANT | NORDITROPIN NORDIFLEX | 6235004 | |
|
|
|||||
| N021447 | 002 | TIZANIDINE HYDROCHLORIDE | ZANAFLEX | 6455557 | |
|
|
|||||
| N021447 | 003 | TIZANIDINE HYDROCHLORIDE | ZANAFLEX | 6455557 | |
|
|
|||||
| N021447 | 001 | TIZANIDINE HYDROCHLORIDE | ZANAFLEX | 6455557 | |
|
|
|||||
| N020771 | 001 | TOLTERODINE TARTRATE | DETROL | 5559269 | |
|
|
|||||
| N020771 | 001 | TOLTERODINE TARTRATE | DETROL | 5559269*PED | |
|
|
|||||
| N020771 | 002 | TOLTERODINE TARTRATE | DETROL | 5559269 | |
|
|
|||||
| N020771 | 002 | TOLTERODINE TARTRATE | DETROL | 5559269*PED | |
|
|
|||||
There have been no patent delistings from the Orange Book in the OTC list since the last Annual Edition.
The following search results are a list of patents that have been DELISTED from the latest Edition (delistings since January 25, 2012) of the Orange Book. Search results display delisted patents from drug products on the DISC list.
| Appl No | Prod No | Active Ingredient | Proprietary Name | Delisted Patent | |
|---|---|---|---|---|---|
| N013217 | 001 | METAXALONE | SKELAXIN | 6407128 | |
|
|
|||||
| N013217 | 001 | METAXALONE | SKELAXIN | 6683102 | |
|
|
|||||
| N020545 | 001 | PROCAINAMIDE HYDROCHLORIDE | PROCANBID | 5656296 | |
|
|
|||||
| N020545 | 002 | PROCAINAMIDE HYDROCHLORIDE | PROCANBID | 5656296 | |
|
|
|||||
Return to Electronic Orange Book Home Page
| FDA/Center for Drug Evaluation and Research |
| Office of Generic Drugs |
| Division of Labeling and Program Support |
| Update Frequency: |
| Orange Book Data - Monthly |
| Generic Drug Product Information & Patent Information - Daily |
| Orange Book Data Updated Through April, 2013 |
| Patent and Generic Drug Product Data Last Updated: May 20, 2013 |
-
